26DT052; Scaling Busulfan Dose to Body Surface Area in Children

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
The goal of this pilot study is to determine if scaling the first busulfan dose to Body Surface Area (BSA) in children with a BSA ≥0.5 m2 and using a BSA-banded dosing table for infants (BSA \<0.5 m2) increases the fraction of patients achieving a therapeutic drug exposure after the first dose.
Epistemonikos ID: a81e9875e337dcd8e98a32450b7007c293b88a34
First added on: Aug 29, 2026